Stocks and Investing Stocks and Investing
Mon, January 23, 2023

Mani Foroohar Maintained (ALNY) at Hold with Decreased Target to $143 on, Jan 23rd, 2023


Published on 2024-10-28 01:02:44 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $144 to $143 on, Jan 23rd, 2023.

Mani has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022


These are the ratings of the 6 analyists that currently disagree with Mani


  • Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $310 on, Wednesday, January 18th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $253 on, Friday, December 16th, 2022
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $415 on, Wednesday, November 2nd, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022
  • Maury Raycroft of "Jefferies" Maintained at Strong Buy with Increased Target to $232 on, Monday, October 3rd, 2022

Contributing Sources